Printer Friendly

EPITOPE RENEWS AIDS DIAGNOSTICS DISTRIBUTION AGREEMENT WITH ORGANON TEKNIKA

 EPITOPE RENEWS AIDS DIAGNOSTICS DISTRIBUTION AGREEMENT
 WITH ORGANON TEKNIKA
 BEAVERTON, Ore., April 27 /PRNewswire/ -- Epitope Inc. (AMEX: EPT) today announced that the company and Organon Teknika Corp., a unit of the Pharma Division of AKZO, N.V. (NASDAQ: AKZOY), have renewed its distribution and supply agreements which provide for exclusive worldwide distribution of Epitope's EPIblot(R) Western blot AIDS confirmatory test kits. The arrangement will extend Organon Teknika's marketing rights for an additional two years.
 "Organon Teknika has been marketing EPIblot since it was introduced in 1987. Our agreements have been revised to allow for more efficient manufacturing by Epitope while affording Organon Teknika the opportunity to continue its effective marketing of the product," said Adolph J. Ferro, president and chief executive officer. He noted that EPIblot is one of only three AIDS confirmatory test kits licensed by the Food and Drug Administration for commercial distribution in the United States. EPIblot accounted for 54 percent of Epitope's revenues in fiscal 1991.
 Epitope Inc. is an Oregon corporation utilizing biotechnology to develop diagnostic tests for AIDS and other indications, therapeutic antimicrobial drugs and, through its agricultural unit, Agritope Inc., superior new plant varieties.
 -0- 4/27/92
 /CONTACT: Mary Hagen of Epitope, 503-641-6115; or Shari Annes of Annes Associates, 415-726-5400, for Epitope/
 (EPT AKZOY) CO: Epitope Inc.; Organon Teknika Corp.; AKZO N.V. ST: Oregon IN: MTC SU:


SC-JH -- SE015 -- 3368 04/27/92 16:39 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 27, 1992
Words:236
Previous Article:HITACHI SOFTWARE, IGS AND UGC CONSULTING DEVELOP CONVERSION TOOLS
Next Article:MULTIBANK FINANCIAL CORP. HOLDS ANNUAL MEETING


Related Articles
MINNTECH ANNOUNCES FIBER SUPPLY CONTRACT WITH ORGANON TEKNIKA B.V.
EPITOPE REPORTS FIRST-QUARTER RESULTS, RECENT DEVELOPMENTS
EPITOPE REPORTS SECOND-QUARTER RESULTS
MEXICO APPROVES EPITOPE'S ORASURE DEVICE, COMPANY SAYS
EPITOPE ANNOUNCES FISCAL 1992 OPERATING RESULTS
EPITOPE ADOPTS ORASURE MANUFACTURING MASTER PLAN
INCSTAR DISCONTINUES R&D ON FLUORESCENCE POLARIZATION IMMUNOASSAY (FPIA) SYSTEM; PURSUES ALTERNATE NEW PRODUCT OPPORTUNITIES
Epitope Announces Publication of Study Regarding its OraSure Oral HIV Antibody Testing System; New York State Approval of OraSure System
Whitman-Walker Clinic Adopts OraSure Oral HIV-1 Antibody Testing System
Epitope Announces OraQuick Development Agreement With Organon Teknika - Dublin, Ireland.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters